For the Inventor, By the Inventor

Enter assignee name

Ea Pharma Co., Ltd.

USPTO Granted Patents = 19

EPO Patents = 18

Trademarks = 1

Forward Citations = 30

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Tamotsu Suzuki (4 out of 44 patents)

Masayuki Sugiki (3 out of 19 patents)

Kaori Kobayashi (3 out of 4 patents)

4. Tatsuya Okuzumi (3 out of 20 patents)

5. Ayatoshi Ando (3 out of 3 patents)

6. Atsushi Tsuruta (2 out of 2 patents)

7. Toshiyuki Takanohashi (2 out of 2 patents)

8. Kenichi Ogawa (2 out of 36 patents)

9. Hirokazu Hagio (2 out of 5 patents)

10. Satoshi Aburatani (2 out of 2 patents)

11. Hirokazu Ueno (2 out of 2 patents)

12. Tomoko Miyazawa (2 out of 2 patents)

13. Munetaka Tokumasu (2 out of 16 patents)

14. Toru Okamatsu (2 out of 6 patents)

15. Shinya Taniguchi (2 out of 3 patents)

19 patents: Sort by Forward Citations

1. 12023320 - Therapeutic agent for fatty liver disease (2024-07-02),

2. RE49569 - Alkylamine derivative (2023-07-03),

3. 11311508 - Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis (2022-04-26),

4. 10626112 - Heterocyclic sulfonamide derivative and medicine comprising same (2020-04-21),

5. 10584116 - Heterocyclic sulfonamide derivative and medicine containing same (2020-03-10),

6. 10562898 - Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity (2020-02-18),

7. 10420741 - Megalin antagonist (2019-09-24),

8. 10226400 - Multi-cell container (2019-03-12),

9. 10183022 - Pharmaceutical composition for treating ulcerative colitis (2019-01-22),

10. 10166234 - Pharmaceutical preparation comprising phenylalanine derivative (2019-01-01),

11. 10039763 - Pharmaceutical preparation comprising phenylalanine derivative (2018-08-07),

12. 9883986 - Standing bag type infusion liquid container (2018-02-06),

13. 9861575 - Vitamin-containing nutrition infusion for administration through peripheral vein (2018-01-09),

14. 9822110 - Sulfonamide derivative and pharmaceutical use thereof (2017-11-21),

15. 9655879 - Heteroarylcarboxylic acid ester derivative (2017-05-23),

EA Pharma Co., Ltd. is a leading pharmaceutical company based in Japan. With a focus on gastroenterology and rheumatology, EA Pharma develops and markets innovative and reliable drugs to improve the well-being of patients. The company is committed to conducting research and delivering high-quality products with the aim of contributing to the advancement of medical care globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#5 in Chuo-ku

#2,975 in Japan

#31,713 in the World

Ea Pharma Co., Ltd.

Forward Citations = 30

78 inventors:

Tamotsu Suzuki (4 out of 44 patents)

Masayuki Sugiki (3 out of 19 patents)

Kaori Kobayashi (3 out of 4 patents)

4. Tatsuya Okuzumi (3 out of 20 patents)

5. Ayatoshi Ando (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…